Preventing pressure ulcers with smart monitoring

AI-driven software that standardises and scales prosthetic socket design to improve access to high-quality prosthetic care worldwide.

MoVax develops oral vaccines. The vaccine survives the gastrointestinal tract because of bio-encapsulation the API inside microbial cells. Microalgae are a highly promising delivery platform for oral vaccines.

At Multiscreening, we developed a patented technology to introduce High Throughput Screening (HTS) for in vivostudies, allowing our customers to increase patent protected market sales by 4 months for each animal experimental series being performed.

Nanoporous MicroNeedle Arrays (npMNAs), integrated into a patch for drug delivery through the skin

MyMicroZoo™ is a company that offers microbiome analysis and web-based tools to gather meta-data (e.g. age, health-status, exercise logs, etc.) as service to the general public, allowing them to gain knowledge and understanding of their microbiota through an innovative platform.

Humanised muscle models for preclinical testing - Leading in compound selection for neuromuscular disorders.

Redefining neuromuscular drug development with advanced tissue models

MYRIAGON is developing a new class of medication to improve the quality of life for patients suffering from chemotherapy-induced neuropathic pain—a serious and often dose-limiting side effect of cancer treatment.